semaglutide diarrhea lawyer in louisiana Louisiana GLP-1 Lawyer Lawsuit Against Ozempic Manufacturers Claims

Description

2026;11(9):e203211.

Both medications are dosed weekly, but semaglutide maintains higher residual levels at the end of each dosing interval relative to its peak

Previous GLP-1 users were far more divided, with 52.34% trusting injections more and 43.75% trusting tablets more, suggesting confidence in tablets may grow once people move away from injectable treatment

At Week 72, the first primary endpoint showed 62.9% of people treated with semaglutide 2.4 mg achieved resolution of steatohepatitis with no worsening of liver fibrosis compared to 34.3% on placebo with estimated difference in responder proportions (EDP) of 28.7% (95% CI, 21.1 to 36.2